Prosecution Insights
Prosecution Insights
51 pending office actions • 19 clients • 49 examiners • 34 art units • 0 of 51 (0%) have an AI response strategy ready • 54 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 23 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 23 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (8%) |
| §103 only | 10 (20%) |
| §112 only | 2 (4%) |
| Double-patenting only | 4 (8%) |
| Double-patenting + other | 6 (12%) |
| Multi-statute (no §101) | 23 (45%) |
| No statute on record | 2 (4%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODRIGUEZ, VICENTE M | 2 | 77.4% | +15.3% |
| MCMILLIAN, KARA RENITA | 2 | 30.4% | +37.9% |
| JACKSON-TONGUE, LAKIA J | 1 | 68.9% | +20.7% |
| THOMAS, KAREEN KAY | 1 | 77.0% | +17.1% |
| STIMPERT, PHILIP EARL | 1 | 62.9% | +49.4% |
| QI, ZHENGQING J | 1 | 68.1% | +12.2% |
| HAUT, EVAN HARRISON | 1 | 60.0% | +0.0% |
| DEHGHAN, QUEENIE S | 1 | 62.1% | +10.9% |
| PRIEST, AARON A | 1 | 61.0% | +25.8% |
| THATCHER, CLINT A | 1 | 80.4% | +11.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18072666 | CONTROL OF SIGNAL CHIRP IN LIDAR SYSTEMS | CHILTON, CLARA GRACE | 50d overdue |
| 18290679 | PTPRS IN AUTOIMMUNITY | KRUSE, DAVID H | 28d overdue |
| 18006011 | GUN SHOT RESIDUE FIELD KIT | FRITCHMAN, REBECCA M | 16d overdue |
| 17435911 | METHOD FOR DETERMINING EFFICACY | MOSS, NATALIE M | 8d overdue |
| 18636709 | SILICON MOLD FOR HIGH TEMPERATURE COMPRESSION MOLDING AND PREPARATION METHOD THEREOF | DEHGHAN, QUEENIE S | 9d |
| 17775217 | BIOMARKER OF DRUG-INDUCED CELLULAR TOXICITY AND DEPRESSION | WESTERBERG, NISSA M | 9d |
| 17049320 | SPIKED PRIMERS FOR ENRICHMENT OF PATHOGEN NUCLEIC ACIDS AMONG BACKGROUND OF NUCLEIC ACIDS | RYAN, DOUGLAS CHARLES | 9d |
| 18271829 | INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS | CRAIGO, BAHAR ALAWI | 23d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18664227 | LIDAR SYSTEM GENERATING MULTIPLE LIDAR OUTPUT SIGNALS | QI, ZHENGQING J | 16d overdue |
| 18636709 | SILICON MOLD FOR HIGH TEMPERATURE COMPRESSION MOLDING AND PREPARATION METHOD THEREOF | DEHGHAN, QUEENIE S | 9d |
| 18904689 | POLYESTER RESIN CLOSURES FOR CONTAINERS | THOMAS, KAREEN KAY | 84d |
| 18940334 | CANCER THERAPY WITH LIVE ATTENUATED BACTERIA | JACKSON-TONGUE, LAKIA J | — |
| 18710478 | BALLOON CATHETER FOR BULB INDUCTION | STIMPERT, PHILIP EARL | — |
| 18620915 | COMPOSITIONS, SYSTEMS, AND METHODS FOR SEQUENCING POLYNUCLEOTIDES USING TETHERS ANCHORED TO POLYMERASES ADJACENT TO NANOPORES | PRIEST, AARON A | — |
| 18607363 | IMAGING SYSTEM WITH INCREASED EFFICIENCY | THATCHER, CLINT A | — |
| 18595334 | DEVICE DETECTION SYSTEM | RODRIGUEZ, VICENTE M | — |
| Art Unit | Apps |
|---|---|
| 3645 | 3 |
| 1623 | 3 |
| 1663 | 2 |
| 1628 | 2 |
| 1678 | 2 |
| 1637 | 2 |
| 1693 | 2 |
| 1635 | 2 |
| 1618 | 2 |
| 3736 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18940334 | CANCER THERAPY WITH LIVE ATTENUATED BACTERIA | Prokarium Limited | JACKSON-TONGUE, LAKIA J | DP | Non-Final OA | — | Pending | Nov 07, 2024 | |
| 18904689 | POLYESTER RESIN CLOSURES FOR CONTAINERS | Origin Materials Operating, Inc. | THOMAS, KAREEN KAY | 3736 | §103 | Non-Final OA | 84d | Pending | Oct 02, 2024 |
| 18710478 | BALLOON CATHETER FOR BULB INDUCTION | Nordlandssykehuset Hf | STIMPERT, PHILIP EARL | §102§103 | Non-Final OA | — | Pending | May 15, 2024 | |
| 18664227 | LIDAR SYSTEM GENERATING MULTIPLE LIDAR OUTPUT SIGNALS | Silc Technologies, Inc. | QI, ZHENGQING J | 3645 | §103 | Non-Final OA | 16d overdue | Pending | May 14, 2024 |
| 18660141 | INCREASING RANGE OF IMAGING SYSTEMS | Silc Technologies, Inc. | HAUT, EVAN HARRISON | §103§112 | Non-Final OA | — | Pending | May 09, 2024 | |
| 18636709 | SILICON MOLD FOR HIGH TEMPERATURE COMPRESSION MOLDING AND PREPARATION METHOD THEREOF | Huatong Optical Technology (Zhejiang) Co., Ltd. | DEHGHAN, QUEENIE S | 1741 | §103§112 | Non-Final OA | 9d | Pending | Apr 16, 2024 |
| 18620915 | COMPOSITIONS, SYSTEMS, AND METHODS FOR SEQUENCING POLYNUCLEOTIDES USING TETHERS ANCHORED TO POLYMERASES ADJACENT TO NANOPORES | Illumina, Inc. | PRIEST, AARON A | §112DP | Non-Final OA | — | Pending | Mar 28, 2024 | |
| 18607363 | IMAGING SYSTEM WITH INCREASED EFFICIENCY | Silc Technologies, Inc. | THATCHER, CLINT A | §102§103 | Non-Final OA | — | Pending | Mar 15, 2024 | |
| 18595334 | DEVICE DETECTION SYSTEM | Silc Technologies, Inc. | RODRIGUEZ, VICENTE M | §102§103§112 | Non-Final OA | — | Pending | Mar 04, 2024 | |
| 18681457 | GENETICALLY ENGINEERED CELL-DERIVED VACCINES | The Regents of the University of California | CHHAY, BONIRATH | 1645 | — | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18290679 | PTPRS IN AUTOIMMUNITY | The Regents of the University of California | KRUSE, DAVID H | 1663 | §102§112 | Non-Final OA | 28d overdue | Pending | Jan 19, 2024 |
| 18573359 | NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE 2A, 2B or 2C AGONISTS | Ldn Pharma Limited | SAMSELL, RILLA MARIE | 1624 | DP | Final Rejection | 20d | Pending | Dec 21, 2023 |
| 18573362 | TREATMENT FOR AUTOIMMUNE DISEASES | Ldn Pharma Limited | MCMILLIAN, KARA RENITA | 1623 | §103§112Other | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18572651 | COMPOSITIONS COMPRISING AN AGONIST OF 5-HYDROXYTRYPTAMINE (5-HT) RECEPTOR SUBTYPE 3 | Ldn Pharma Limited | CLARK, AMY LYNN | 1628 | §102§103§112 | Non-Final OA | 83d | Pending | Dec 20, 2023 |
| 18572637 | NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILTY OF 5-HT RECEPTOR AGONISTS | Ldn Pharma Limited | SAEED, ALI S | 1616 | §103§112DPOther | Non-Final OA | 76d | Pending | Dec 20, 2023 |
| 18539251 | AMPLIFICATION OF SIGNALS IN IMAGING SYSTEMS | Silc Technologies, Inc. | DECARIA, MICHAEL ALEX | 4100 | §103§112 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18285222 | BLOCKING OLIGONUCLEOTIDES FOR THE SELECTIVE DEPLETION OF NON-DESIRABLE FRAGMENTS FROM AMPLIFIED LIBRARIES | Illumina, Inc. | CASH, KAILEY ELIZABETH | 1683 | §102§103§112 | Non-Final OA | 70d | Pending | Sep 29, 2023 |
| 18284682 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited | MCMILLIAN, KARA RENITA | 1623 | §112 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18284783 | DETECTION ASSAY | Randox Teoranta | HAQ, SHAFIQUL | 1678 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18280093 | USE OF MESENCHYMAL STEM CELLS OVEREXPRESSING PACER FOR THE TREATMENT OF DISEASES WITH INFLAMMATORY ORIGIN AND/OR COMPONENT | Universidad del Desarrollo | RAHMAN, MASUDUR | 1633 | §101§103§112 | Non-Final OA | 39d | Pending | Sep 01, 2023 |
| 18231114 | AUTOIMMUNE THERAPY | Ldn Pharma Limited | COPPINS, JANET L | 1628 | §103§112 | Final Rejection | 83d | Pending | Aug 07, 2023 |
| 18226739 | DEVICES AND METHODS FOR CONTINUOUS DIELECTROPHORESIS CELL SORTING TO ISOLATE DIFFERENT POPULATIONS OF CELLS, AND APPLICATIONS THEREOF | The Regents of the University of California | LYLE, SOPHIA YUAN | 1796 | §103§112 | Non-Final OA | 65d | Pending | Jul 26, 2023 |
| 18271829 | INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS | Saga University | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112 | Non-Final OA | 23d | Pending | Jul 11, 2023 |
| 18271832 | RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF | The Regents of the University of California | ALLEN, SARAH ELIZABETH | 1637 | §102§103§112DPOther | Non-Final OA | — | Pending | Jul 11, 2023 |
| 17924554 | COMPOSITION COMPRISING PEPTIDE, AND USE THEREOF | Kola-Gen Pharma Inc. | BOWLES, DAVID PAUL | 1654 | §102§103§112DP | Non-Final OA | 83d | Pending | Jun 12, 2023 |
| 18029470 | ENDOSOMAL ESCAPE DOMAINS FOR DELIVERY OF MACROMOLECULES INTO CELLS | The Regents of the University of California | MCINTOSH III, TRAVISS C | 1693 | §102§112 | Non-Final OA | — | Pending | Mar 30, 2023 |
| 18026480 | CHARGED MEMBRANES INCORPORATED WITH POROUS POLYMER FRAMEWORKS | The Regents of the University of California | CHIU, TAK LIANG | 1777 | §103§112 | Final Rejection | — | Pending | Mar 15, 2023 |
| 18022630 | siRNA AND USE THEREOF | Ohara Pharmaceutical Co., Ltd. | SHIN, DANA H | 1635 | Other | Non-Final OA | — | Pending | Feb 22, 2023 |
| 18100204 | IMMUNOMODULATORY OLIGOSACCHARIDES | The Regents of the University of California | BAKSHI, PANCHAM | 1623 | §103 | Non-Final OA | — | Pending | Jan 23, 2023 |
| 18006011 | GUN SHOT RESIDUE FIELD KIT | VERITEQUE USA, INC. | FRITCHMAN, REBECCA M | 1758 | §103§112 | Non-Final OA | 16d overdue | Pending | Jan 19, 2023 |
| 18074402 | ENGINEERED VASCULARIZED ORGANOIDS | The Regents of the University of California | THUESON, HANNA MARIE | 1638 | §103 | Non-Final OA | — | Pending | Dec 02, 2022 |
| 18072666 | CONTROL OF SIGNAL CHIRP IN LIDAR SYSTEMS | Silc Technologies, Inc. | CHILTON, CLARA GRACE | 3645 | §102§103§112 | Final Rejection | 50d overdue | Pending | Nov 30, 2022 |
| 17924080 | VECTORS AND METHODS FOR IN VIVO TRANSDUCTION | Abintus Bio, Inc. | JACKSON III, WALTER | 1674 | §102§103§112 | Non-Final OA | — | Pending | Nov 08, 2022 |
| 17920379 | UNIVERSAL PRIMERS FOR DETECTION OF BACTERIA, FUNGI AND EUKARYOTIC MICROORGANISMS | The Regents of the University of California | BERTAGNA, ANGELA MARIE | 1681 | §101§102§112 | Final Rejection | — | Pending | Oct 20, 2022 |
| 17970508 | IDENTIFICATION OF CHIRP RATES | Silc Technologies, Inc. | NAPIER, JAMES WILBURN | 3645 | §102§103 | Final Rejection | — | Pending | Oct 20, 2022 |
| 18048386 | THERAPIES AND METHODS TO TREAT TLR2-MEDIATED DISEASES AND DISORDERS | The Regents of the University of California | SZPERKA, MICHAEL EDWARD | 1641 | §102§112DP | Non-Final OA | 26d | Pending | Oct 20, 2022 |
| 17912313 | SCREENING METHODS TO IDENTIFY SMALL MOLECULE COMPOUNDS THAT PROMOTE OR INHIBIT THE GROWTH OF CIRCULATING TUMOR CELLS, AND USES THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | — | Pending | Sep 16, 2022 |
| 17786913 | BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS | The Regents of the University of California | RAMIREZ, DELIA M | 1652 | DP | Non-Final OA | 43d overdue | Pending | Jun 17, 2022 |
| 17781686 | ENGINEERING CIRCULAR GUIDE RNAS | The Regents of the University of California | BUI, PHUONG T | 1663 | §102§112 | Non-Final OA | — | Pending | Jun 01, 2022 |
| 17775217 | BIOMARKER OF DRUG-INDUCED CELLULAR TOXICITY AND DEPRESSION | Randox Laboratories Ltd. | WESTERBERG, NISSA M | 1618 | §101§103§112 | Final Rejection | 9d | Pending | May 06, 2022 |
| 17640758 | NUCLEIC ACID-MEDIATED DELIVERY OF THERAPEUTICS | Pharmaresearch Co., Ltd. | CHO, DAVID H | 1693 | §103 | Non-Final OA | — | Pending | Mar 04, 2022 |
| 17617278 | BIOCIDAL COMPOSITE MATERIAL | Pennog Limited | TRUONG, QUANGLONG N | 1615 | §103 | Non-Final OA | 84d | Pending | Dec 07, 2021 |
| 17602150 | LONG-LASTING ANALGESIA VIA TARGETED IN VIVO EPIGENETIC REPRESSION | The Regents of the University of California | TRAN, CHRISTINA L | 1637 | §112 | Non-Final OA | — | Pending | Oct 07, 2021 |
| 17435911 | METHOD FOR DETERMINING EFFICACY | Ldn Pharma Limited | MOSS, NATALIE M | 1653 | §103§112 | Non-Final OA | 8d overdue | Pending | Sep 02, 2021 |
| 17419239 | CAR T CELL METHODS AND CONSTRUCTS | Abintus Bio, Inc. | KIM, TAEYOON | 1631 | §103§112 | Final Rejection | — | Pending | Jun 28, 2021 |
| 17294358 | DETECTION OF BLADDER CANCER | Randox Laboratories Ltd. | MONTGOMERY, ANN Y | 1678 | §101§103 | Non-Final OA | 28d | Pending | May 14, 2021 |
| 17221770 | USE OF CIRCULATOR IN LIDAR SYSTEM | Silc Technologies, Inc. | RODRIGUEZ, VICENTE M | 3642 | §103 | Final Rejection | — | Pending | Apr 02, 2021 |
| 17278200 | PTPRS AND PROTEOGLYCANS IN RHEUMATOID ARTHRITIS | The Regents of the University of California | EDGINGTONGIORDANO, FRANCESCA | 1643 | §103§112DP | Non-Final OA | — | Pending | Mar 19, 2021 |
| 17049320 | SPIKED PRIMERS FOR ENRICHMENT OF PATHOGEN NUCLEIC ACIDS AMONG BACKGROUND OF NUCLEIC ACIDS | The Regents of the University of California | RYAN, DOUGLAS CHARLES | 1635 | §103§112 | Non-Final OA | 9d | Pending | Oct 20, 2020 |
| 17025836 | GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA | The Regents of the University of California | DHAR, MATASHA | 1632 | DP | Final Rejection | — | Pending | Sep 18, 2020 |
| 16776405 | PATHOGEN DETECTION USING NEXT GENERATION SEQUENCING | The Regents of the University of California | DHARITHREESAN, NIDHI | 1686 | §103 | Final Rejection | 33d | Pending | Jan 29, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial